GSK-163090

DB33638InvestigationalSmall molecule

GSK-163090: Overview.

Chemical structure of GSK-163090
Formula / weight
C25H29N5O · 415.541 g/mol (avg)
Code names
GSK-163090

Resolves to

Compound
UNII7XI927X82BCAS844903-58-8ChEMBLCHEMBL1631540ChEBI749937PubChem11292933
Structure
InChIKeyANGUXJDGJCHGOG-UHFFFAOYSA-NSMILESCC1=CC=C2C(C=CC=C2N2CCN(CCC3=CC(=CC=C3)N3CCNC3=O)CC2)=N1
Targets
P08908HTR1A

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with GSK-163090, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In